Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal clindamycin and dexamethasone for acute toxoplasma chorioretinitis-associated vitritis
2006-005008-15Phase 4Terminated
- Sponsor
- Moorfields Eye Hospital
- Start
- Oct 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clindamycin and dexamethasone in ocular toxoplasmosis and Hyalitis, sponsored by Moorfields Eye Hospital. Primary endpoint: Quiescence of toxoplasma chorioretinitis. Started Oct 2006; status: terminated.
02
Drugs
clindamycindexamethasone
03
Conditions
ocular toxoplasmosisHyalitis
Beyond the preview
Go deeper on 2006-005008-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005008-15.